• Fetck KC Callout
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 Insights™
dvm360 LIVE!™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Perception Versus Reality: Insecticide Resistance in Fleas

June 18, 2017
American Veterinarian, June 2017, Volume 2, Issue 3

Are modern flea control products ineffective? A review of recent research answers this important question.

Research shows that the common cat flea (Ctenocephalides felis felis) has developed resistance to some flea control products that have been used on pets and in the environment for many decades, such as organophosphates, pyrethroids, and carbamates.

Now, however, concern has grown that because of the development and widespread use of newer products, including convenient oral and topical agents, fleas could be showing evidence of resistance to these chemicals. According to Michael K. Rust, PhD, professor of entomology at the University of California, Riverside, research does not support the suggestion that they are. Dr. Rust discussed his recent work in a review article published in Insects.

In his review, Dr. Rust defined and challenged the concept of resistance by examining research published throughout the world on hundreds of flea strains known to parasitize cats and dogs. Laboratory simulations and on-animal studies were included in his analysis, which used laboratory animals, pets, and dogs and cats representing stray populations. Chemical susceptibility studies involving multiple stages of C. felis (larvae, eggs, and adults) were reviewed, and laboratory data detailing genetic mutations known to be responsible for the development of resistance among fleas were incorporated into the analysis.

What Does Resistance Really Mean?

Dr. Rust defined resistance as “a heritable change in the sensitivity of a pest population that is reflected in the repeated failure of a product to achieve the expected level of control when used according to the label recommendation for that pest species.” Although resistance has been documented for some traditional flea control products used in the environment and on pets, he notes that significant decreases in susceptibility have not been demonstrated for the neonicotinoids (eg, imidacloprid, dinotefuran) or phenylpyrazoles (eg, fipronil).

Researchers investigating insecticide resistance typically consider a list of variables that may contribute to the required genetic mutations in fleas. These can include the number of offspring a flea strain typically produces for each generation, how quickly new generations are born and reproduce, and the number of generations produced per year. Other factors affecting the likelihood of insecticide resistance include the chemical behavior of the insecticide itself, how long residues persist in the environment and on pets, and how many treatments are required to achieve the desired effect.

Conversely, certain factors tend to help reduce the chances of resistance developing for a specific insecticide. These factors include using a chemical that is effective against more than 1 flea life stage (eg, a product that is adulticidal, larvicidal, and/or ovicidal). Products that kill adult fleas quickly enough to prevent feeding and egg deposition may have an advantage, Dr. Rust notes, as they help disrupt the life cycle (by preventing egg production) and prevent access to adult flea feces that larvae need for their development.

Similarly, products that interrupt flea development in the environment are less likely to be associated with resistance. Agents such as fluralaner, lufenuron, methoprene, pyriproxyfen, selamectin, fipronil, and imidacloprid have this advantage. Further, products that demonstrate multiple modes of action or synergism between their chemical components may have an advantage that limits the likelihood of fleas developing resistance. Dr. Rust points out study results that suggest possible synergism between methoprene and fipronil and between pyriproxyfen and methoprene.

Research Does Not Prove Resistance

Dr. Rust writes: “Since the introduction of the [insect growth regulators] lufenuron, fipronil, and imidacloprid in the mid-1990s, there has been little direct evidence of resistance developing to them.” Although variability in responses by some flea strains to fipronil and imidacloprid has been noted, he comments that there has been no significant reduction in the susceptibility of fleas to these agents. His findings make a compelling case for the assertion that resistance to newer products such as fipronil and imidacloprid has not been proven based on available data.

He does caution, however, that “product failures” have been reported for some currently used flea control products, but these failures can generally be attributed to improper use of the product and not to fleas’ resistance to the active ingredients. According to Dr. Rust, inappropriate application or administration of the product, failure to treat all pets in the household, frequent bathing (which can reduce the effectiveness of some topical products), and discontinuing treatment during the winter months can contribute to treatment failure. Additionally, pets that have been treated successfully with a product can become reinfested with fleas, which could be misinterpreted by some pet owners as a treatment failure. Urban and suburban wildlife, such as raccoons and opossums, can contribute to reinfestation of household pets that venture outdoors.

Fleas are a significant parasite affecting the overall health and well-being of cats, dogs, and the humans who share their lives. Veterinarians and researchers should understand how chemical resistance develops, become familiar with factors that help reduce the likelihood of chemical resistance, and work to help determine the best ways to prolong the longevity of the safe and highly effective parasiticides currently on the market.

Dr. Todd-Jenkins received her VMD degree from the University of Pennsylvania School of Veterinary Medicine. She is a medical writer and has remained in clinical practice for over 20 years. She is a member of the American Medical Writers Association and One Health Initiative.

download issueDownload Issue: June 2017

Related Content:

ParasitologyJune 2017
A paradigm shift to leptospirosis as a small dog disease
A paradigm shift to leptospirosis as a small dog disease
Mitigating leptospirosis with vaccines that reduce both transmission and circulation in the bloodstream
Mitigating leptospirosis with vaccines that reduce both transmission and circulation in the bloodstream
Leptospirosis and its serovars: a re-emerging pathogen
Leptospirosis and its serovars: a re-emerging pathogen

Latest News

Mini donkey successfully receives pacemaker to manage fatal heart condition

News wrap-up: This week’s headlines, plus Cincinnati Zoo welcomes baby hippo

Dr Mike Nolan receives 2022 AVMF/EveryCat Health Foundation Research Award

Lear's macaw reintroduced into wild and flourishing

View More Latest News